Erratum to: Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis

Overview of attention for article published in Applied Health Economics and Health Policy, September 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 6 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma : Committee papers

Cited by National Institute for Health and Care Excellence on 16 Sep 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.